{"id":"https://openalex.org/W2295047366","doi":"https://doi.org/10.2147/dddt.s103423","title":"Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis","display_name":"Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis","publication_year":2016,"publication_date":"2016-03-01","ids":{"openalex":"https://openalex.org/W2295047366","doi":"https://doi.org/10.2147/dddt.s103423","mag":"2295047366","pmid":"https://pubmed.ncbi.nlm.nih.gov/27022248","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4790491"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s103423","doi":"https://doi.org/10.2147/dddt.s103423","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s103423","pdf_url":"https://www.dovepress.com/getfile.php?fileID=29367","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=29367","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114030656","display_name":"Amal Kamal Hussein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Amal Hussein","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035480188","display_name":"T El-Ammawi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tarek El- Ammawi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036490274","display_name":"Fatma Mohammed Mady","orcid":"https://orcid.org/0000-0002-2865-145X","observed_orcids":["https://orcid.org/0000-0002-2865-145X"]},"institutions":[{"id":"https://openalex.org/I23075662","display_name":"Taibah University","ror":"https://ror.org/01xv1nn60","country_code":"SA","type":"education","lineage":["https://openalex.org/I23075662"]},{"id":"https://openalex.org/I4210155890","display_name":"Minia University Hospital","ror":"https://ror.org/04jqt3k72","country_code":"EG","type":"healthcare","lineage":["https://openalex.org/I4210155890"]},{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG","SA"],"is_corresponding":false,"raw_author_name":"Fatma Mady","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Taibah University, Medina, Saudi Arabia; Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt","Department of Dermatology, sTDs, and andrology, Minia University hospital, Minia, egypt","Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Taibah University, Medina, saudi arabia;","Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Taibah University, Medina, Saudi Arabia; Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt","institution_ids":["https://openalex.org/I23075662","https://openalex.org/I89466785"]},{"raw_affiliation_string":"Department of Dermatology, sTDs, and andrology, Minia University hospital, Minia, egypt","institution_ids":["https://openalex.org/I4210155890"]},{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Taibah University, Medina, saudi arabia;","institution_ids":["https://openalex.org/I23075662"]},{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, egypt;","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043474868","display_name":"Hamdy Abdelkader","orcid":"https://orcid.org/0000-0003-4989-5143","observed_orcids":["https://orcid.org/0000-0003-4989-5143","https://orcid.org/0000-0002-0460-9812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hamdy Abd elkader","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002319732","display_name":"Hanaa L. Essa","orcid":"https://orcid.org/0000-0002-7216-5176","observed_orcids":["https://orcid.org/0000-0002-7216-5176"]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hanaa Essa","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt","institution_ids":["https://openalex.org/I89466785"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5114030656"],"corresponding_institution_ids":["https://openalex.org/I89466785"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":3.6147,"has_fulltext":true,"cited_by_count":55,"citation_normalized_percentile":{"value":0.92160175,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"10","issue":null,"first_page":"1101","last_page":"1101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.984000027179718},{"id":"https://openalex.org/keywords/pluronic-lecithin-organogel","display_name":"pluronic lecithin organogel","score":0.8930000066757202},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.8560000061988831},{"id":"https://openalex.org/keywords/skin-absorption","display_name":"percutaneous absorption","score":0.8659999966621399},{"id":"https://openalex.org/keywords/dimethyl-sulfoxide","display_name":"dimethyl sulfoxide","score":0.6589999794960022},{"id":"https://openalex.org/keywords/gel-formulation-optimization","display_name":"gel formulation optimization","score":0.5820000171661377},{"id":"https://openalex.org/keywords/in-vitro-skin-permeation","display_name":"in vitro skin permeation","score":0.781000018119812},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.8169558048248291},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.8035367727279663},{"id":"https://openalex.org/C2779564620","wikidata":"https://www.wikidata.org/wiki/Q241595","display_name":"Lecithin","level":2,"score":0.663597583770752},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5842058658599854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4838084578514099},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.32538658380508423},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2725791931152344},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13868865370750427},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D054709","descriptor_name":"Lecithins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054709","descriptor_name":"Lecithins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2147/dddt.s103423","doi":"https://doi.org/10.2147/dddt.s103423","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s103423","pdf_url":"https://www.dovepress.com/getfile.php?fileID=29367","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3774954","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4790491","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4790491","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4790491","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmid:27022248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27022248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1e31efcba00140ffa0554a433a49ed08","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1e31efcba00140ffa0554a433a49ed08","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 1101-1110 (2016)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/25942","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/formulation-and-clinical-evaluation-of-silymarin-pluronic-lecithin-org-peer-reviewed-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s103423","doi":"https://doi.org/10.2147/dddt.s103423","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s103423","pdf_url":"https://www.dovepress.com/getfile.php?fileID=29367","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2295047366.pdf","grobid_xml":"https://content.openalex.org/works/W2295047366.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W104920618","https://openalex.org/W191268206","https://openalex.org/W1466435411","https://openalex.org/W1495097957","https://openalex.org/W1559244578","https://openalex.org/W1965918246","https://openalex.org/W1966161984","https://openalex.org/W1973760627","https://openalex.org/W1974226203","https://openalex.org/W1975872727","https://openalex.org/W1983293884","https://openalex.org/W1984802375","https://openalex.org/W1988223087","https://openalex.org/W2010070065","https://openalex.org/W2027109953","https://openalex.org/W2027501187","https://openalex.org/W2039800741","https://openalex.org/W2042102056","https://openalex.org/W2046067198","https://openalex.org/W2053642508","https://openalex.org/W2062653267","https://openalex.org/W2081818133","https://openalex.org/W2085527615","https://openalex.org/W2086610213","https://openalex.org/W2103006123","https://openalex.org/W2119560897","https://openalex.org/W2138350693","https://openalex.org/W2141638038","https://openalex.org/W2147237985","https://openalex.org/W2151680183","https://openalex.org/W2157657114","https://openalex.org/W2342184858","https://openalex.org/W3134986606"],"related_works":["https://openalex.org/W4383813098","https://openalex.org/W4309931608","https://openalex.org/W2010132385","https://openalex.org/W7215774512","https://openalex.org/W4319600256","https://openalex.org/W4280546514","https://openalex.org/W2072511784","https://openalex.org/W7126193917","https://openalex.org/W4408572510","https://openalex.org/W2036076997"],"abstract_inverted_index":{"Silymarin":[0],"is":[1,49],"a":[2,16,141],"naturally":[3],"occurring":[4],"flavonoid":[5],"drug;":[6],"evidence":[7],"from":[8],"recent":[9],"research":[10],"has":[11],"highlighted":[12],"its":[13],"use":[14],"as":[15,97,122,140],"potential":[17],"treatment":[18,143],"for":[19,45,92,132,144],"atopic":[20],"dermatitis":[21],"(AD).":[22],"Both":[23],"poor":[24],"water":[25],"solubility":[26],"and":[27,75,82,105,125],"drug":[28,103],"permeability":[29],"have":[30],"hindered":[31],"the":[32,50,89,130],"percutaneous":[33],"absorption":[34],"of":[35,38,53,72,95,119,134],"silymarin.":[36],"Formulation":[37,78],"silymarin":[39,96,109,112,137],"into":[40],"pluronic-lecithin":[41],"organogel":[42],"(PLO)":[43],"basis":[44],"topical":[46,93],"skin":[47],"delivery":[48,94],"main":[51],"aim":[52],"this":[54],"work.":[55],"Six":[56],"different":[57],"PLO":[58,113,138],"formulations":[59,139],"were":[60],"prepared":[61],"containing":[62],"various":[63],"pluronic":[64,81],"to":[65,87],"lecithin":[66],"ratios":[67],"using":[68],"two":[69],"cosolvent":[70],"systems":[71],"ethyl":[73],"alcohol":[74],"dimethyl":[76],"sulfoxide.":[77],"2":[79],"(20%":[80],"3%":[83],"lecithin)":[84],"was":[85],"found":[86],"be":[88],"optimal":[90],"base":[91],"it":[98],"showed":[99],"optimum":[100],"pH,":[101],"viscosity,":[102],"content,":[104],"satisfactory":[106],"in":[107],"vitro":[108],"permeation.":[110],"The":[111],"formulation":[114],"significantly":[115],"relieved":[116],"inflammatory":[117],"symptoms":[118],"AD":[120],"such":[121],"redness,":[123],"swelling,":[124],"inflammation.":[126],"These":[127],"findings":[128],"warrant":[129],"ability":[131],"application":[133],"these":[135],"novel":[136,142],"AD.":[145]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}